Nortopixantrone HCl

CAS No. 438244-41-8

Nortopixantrone HCl( —— )

Catalog No. M34350 CAS No. 438244-41-8

Nortopixantrone HCl (BBR 3438) is a novel 9-azacyclonopyrazole that shows antitumor activity in a human prostate cancer model.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 922 In Stock
10MG 1121 In Stock
25MG 1501 In Stock
50MG 1841 In Stock
100MG 2325 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nortopixantrone HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Nortopixantrone HCl (BBR 3438) is a novel 9-azacyclonopyrazole that shows antitumor activity in a human prostate cancer model.
  • Description
    Nortopixantrone HCl (BBR 3438) is a novel 9-azacyclonopyrazole that shows antitumor activity in a human prostate cancer model.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    438244-41-8
  • Formula Weight
    453.36
  • Molecular Formula
    C20H26Cl2N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C2=C(C3=NN(CCNCCO)C4=CC=C(C1=C34)NCCNC)C=NC=C2.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Deoxybenzoin

    Deoxybenzoin is used to target immune sensors and xanthine oxidase. It is used for the treatment of gout.

  • Biotin-pTH-Related P...

    Biotin-pTH-Related Protein (1-34) (human, mouse, rat)

  • BDC2.5 mimotope 1040...

    BDC2.5 mimotope 1040-51 is a mimotope peptide for diabetogenic T cell clone BDC2.5. isolated from non-obese diabetic mice.This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. from non-obese diabetic (NOD) mice. T cells from prediabetic and diabetic NODs respond to BDC2.5 mimotope peptides.